Medpace Holdings, Inc. (MEDP) is a Technology stock trading at $460.24 (as of 2026-06-18), with a market capitalization of $12.77B and a trailing P/E of 28.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Medpace Holdings, Inc. provides clinical research services for drug and medical device development across North America, Europe, and Asia, supporting clinical development through multiple trial phases and therapeutic areas. Its offerings include clinical development and regulatory-related services, plus supporting laboratory and specialty services such as bioanalytical testing and clinical human pharmacology, for pharmaceutical, biotechnology, and medical device organizations.